EMMA Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Emmaus Life Sciences Inc

Watchlist Manager

Watchlist

Price: 0.0602 USD -15.21% Market Closed

Market Cap: $4.2m

	Emmaus Life Sciences Inc OTC:EMMA	US
M	Mitie Group PLC DUS:MZ4	UK

Profitability Summary

Emmaus Life Sciences Inc's profitability score is 58/100. We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

94%

Strong 3Y Average Gross Margin

94%

Gross Margin is Increasing

93% > 94%

Healthy Operating Margin

29%

Low 3Y Average Operating Margin

Operating Margin is Increasing

-1% > 29%

Negative Net Margin

-39%

Negative 3Y Average Net Margin

-34%

Declining Net Margin

-18% > -39%

Exceptional Free Cash Flow Margin

26%

Negative 3Y Average Free Cash Flow Margin

-5%

Free Cash Flow Margin is Increasing

-7% > 26%

Low ROE

10%

Positive 3Y Average ROE

View All

Hide

Collapse

58 / 100

Profitability
Score

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.